Skip to content

S.B Pharma

Active Risk: moderate
Limited partnershipfounded 2025active for 1 yearVoetbalstraat 14, 2610 Antwerpen, BelgiumKBO/BCE: BE 1024.995.832
Risk analysisFollow ReportCompare
S.B PharmaActive
Risk analysis ReportCompare

Acts, filings and financial milestones

2025
04-07
Gazette deed Incorporation
Starting capital €100 · Appointment: Boumazzoughe Sana (manager) · Founder12 points ▸
  • Founder, Boumazzoughe Sana
  • Founder, Boumazzoughe Younes
  • Incorporation, “S.B Pharma” (deed in Dutch)
  • Founding capital, €100
  • Pre-incorporation commitments, “takeover, alle verbintenissen die tot op heden in haar naam aangegaan werden” (deed in Dutch)
  • Partner, Boumazzoughe Sana (general partner)
  • Partner, Boumazzoughe Younes (limited partner)
  • Capital, “euro 100” (deed in Dutch)
  • Kind of shares, “op naam”, 100 (deed in Dutch)
  • Director appointment, Boumazzoughe Sana (manager)
  • Pre-incorporation commitments, ratification, “alle rechtshandelingen in naam en voor rekening van vennootschap verricht voor verkrijging rechtspersoonlijkheid” (deed in Dutch)
  • Other provision, “onbeperkt, KBO-communicatie” (deed in Dutch)

Open the act in the Belgian Official Gazette

Gazette deed

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

We would like to set cookies. That happens only with your consent. What we measure